A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA

NCT00006430 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

NIH

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: Autologous dendritic cells transfected with amplified tumor RNA

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]